Last reviewed · How we verify

NCT04173182

Confocal Laser Endomicrospy in Colonic Diverticular Disease

Completed Last updated 31 March 2022
What this trial tests

trial testing Probe-based confocal laser endomicroscopy evaluation in Diverticular Disease in 63 participants. Completed in 1 March 2021.

Timeline
1 November 2019
Primary endpoint
1 February 2021
1 March 2021

Quick facts

Lead sponsorInstituto Ecuatoriano de Enfermedades Digestivas
StatusCompleted
Study typeOBSERVATIONAL
Enrollment63
Start date1 November 2019
Primary completion1 February 2021
Estimated completion1 March 2021
Sites1 location across Ecuador

Drugs / interventions tested

Conditions studied

Sponsor

Instituto Ecuatoriano de Enfermedades Digestivas — full company profile →

Who can join

Adults 18 to 80, any sex, with Diverticular Disease or Diverticulitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Confocal laser endomicroscopy detects inflammatory markers undetectable during high definition endoscopy. The investigators aimed to evaluate the role of peridiverticular and colonic mucosa inflammation in the prediction of the complicated diverticular disease using confocal laser endomicroscopy evaluation in the peridiverticular area in consecutive patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Instituto Ecuatoriano de Enfermedades Digestivas trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04173182.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing